Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presatovir in HCT Recipients with RSV URTI
NCT02254408Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jan 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of presatovir in respiratory syncytial virus infection (RSV), sponsored by Gilead Sciences. Started Jan 2015; status: completed.
02
Drugs
presatovir
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02254408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254408.